Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.

导出 OA

翻译打印收藏纠错

第一作者： Pei,Cao

第一单位： Department of General Surgery,The First Affiliated Hospital of Soochow University, Suzhou, China.

作者： Pei,Cao ^[1] ; Weigang,Zhang ^[1] ; Junyi,Qiu ^[1] ; Zuxiong,Tang ^[1] ; Xiaofeng,Xue ^[1] ; Tingting,Feng ^[2]

作者单位： Department of General Surgery,The First Affiliated Hospital of Soochow University, Suzhou, China. ^[1] Department of Infectious Disease,The First Affiliated Hospital of Soochow University, Suzhou, China. ^[2]

关键词 Gemcitabine MYC Pancreatic neoplasms RNA methylation WTAP

主题词人类(Humans);胰腺肿瘤(Pancreatic Neoplasms);腺嘌呤(Adenine);腺苷(Adenosine);细胞周期蛋白质类(Cell Cycle Proteins)

DOI 10.4143/crt.2022.1600

PMID 37591781

发布时间 2024-01-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cancer research and treatment

2024年56卷1期

259-271页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.

Cancer research and treatment

相似文献

Cancer research and treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.

Cancer research and treatment

相似文献

Cancer research and treatment

相关期刊

检索历史清除